DUBLIN, August 19, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Antibodies Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.
This report offers a 10-year forecast on the global market for antibodies between 2016 and 2026. The global antibodies market is expected to witness a robust CAGR of 12.5% over the forecast period. The study demonstrates market dynamics that are expected to influence the current environment and future status of the global antibodies market over the forecast period.
The primary objective of this report is to offer updates on trends, drivers, restraints, value forecasts, and opportunities for manufacturers operating in the global antibodies market.
Global demand for antibodies is increasing with growing burden of chronic illnesses such as cancer, autoimmune disorders and others. Developed markets such as the U.S. and Europe are witnessing increasing demand for antibody-based drugs due to rising demand for better treatment options.
To understand and analyse the market, the report is categorically split into four sections, viz. market analysis by drug type, end user, indication, and regions. The report analyses the global antibodies market in terms of value (US$ Mn).
Scope of the Report
The global antibodies market is segmented on the basis of
- Drug type
- End User
- Disease Indication
Drug types covered in the report include:
- Monoclonal antibodies
- Polyclonal antibodies
- Antibody drug conjugates
The end users covered in this report are:
- Long-term care facilities
- Research institutes
The indications covered in the report include:
- CNS Disorders
- Cardiovascular Diseases
- Autoimmune disorders
Key players in the market include
- AbbVie Inc.
- Amgen Inc.
- Biogen Inc.
- Bristol-Myers Squibb Company
- Eli Lilly and Co.
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson Services Inc.
- Novartis AG
- Takeda Pharmaceutical Company Limited
For more information about this report visit http://www.researchandmarkets.com/research/lxrctr/antibodies
Related Topics: Biopharmaceuticals
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-antibodies-industry-analysis-and-opportunity-assessment-2016-2026---breakdown-by-drug-type-end-user-disease-indication--regions---research-and-markets-300315874.html
SOURCE Research and Markets